TAAM
KYNB

Top Ace Asset Management’s Kyntra Bio KYNB Stock Holding History

Top Ace Asset Management’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-9,896
Closed -$5.12M – 20
2016
Q3 		$5.12M Buy
+9,896
New +$4.66M 5.51% 7
2015
Q3 		– Sell
-1,600
Closed -$940K – 24
2015
Q2 		$940K Buy
+1,600
New +$931K 0.75% 12

Other funds holding KYNB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Top Ace Asset Management's KYNB Position: Q4 2016 in Review

Top Ace Asset Management sold out of Kyntra Bio (KYNB) in Q4 2016, closing a stake of 9,896 shares — an estimated $5.12M sold.

Top Ace Asset Management first reported a position in KYNB in Q2 2015 and held it in 2 quarters. The position peaked at $5.12M in Q3 2016. 140 funds tracked by Wall St. Rank hold KYNB as of Q4 2016.

  • Top Ace Asset Management reported no remaining Kyntra Bio position as of Q4 2016 after selling out during the quarter.
  • Top Ace Asset Management sold 9,896 Kyntra Bio shares in Q4 2016, an estimated $5.12M.
  • Top Ace Asset Management first reported a position in Kyntra Bio in Q2 2015 and held it in 2 quarters.
  • Top Ace Asset Management's Kyntra Bio position peaked at $5.12M in Q3 2016.
  • 140 funds tracked by Wall St. Rank held Kyntra Bio as of Q4 2016.

Based on Top Ace Asset Management's 13F filing for Q4 2016, filed 6 Feb 2017.